A randomised, double blind, placebo controlled, parallell group, phase 1 study to assess the safety, tolerability and pharmacokinetics of single and mutlitple ascending oral doses of AZD9668 in healthy japanese and caucasion volunteers

Study identifier:D0520C00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomised, double blind, placebo controlled, parallell group, phase 1 study to assess the safety, tolerability and pharmacokinetics of single and mutlitple ascending oral doses of AZD9668 in healthy japanese and caucasion volunteers

Medical condition

pharmacokinetics

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Nov 2007
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria